Table 4.
Linear regression of U-sugars, added sugar intake and their composite measure (PC) on cardiometabolic risk factors in the Malmö Offspring Study.
| All | Women | Men | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | ß | 95% CI | P-int sex | n | ß | 95% CI | n | ß | 95% CI | |
| BMI (kg/m2) | ||||||||||
| U-sugars (μmol·L−1)/(mOsm·kg−1) | ||||||||||
| Model 1 | 763 | 0.15 | −0.45, 0.77 | 412 | 1.03 | 0.14, 1.92 | 351 | −1.00 | −1.84, −0.16 | |
| Model 2 | 677 | 0.08 | −0.58, 0.74 | <0.01 | 381 | 1.05 | 0.12, 1.97 | 296 | −1.45 | −2.40, −0.51 |
| Added sugar (E%) | ||||||||||
| Model 1 | 991 | 0.08 | 0.02, 0.13 | 533 | 0.14 | 0.06, 0.22 | 458 | 0.01 | −0.05, 0.08 | |
| Model 2 | 889 | 0.03 | −0.03, 0.09 | 0.03 | 493 | 0.10 | 0.01, 0.19 | 396 | −0.03 | −0.10, 0.05 |
| Composite measure | ||||||||||
| Model 1 | 763 | 0.35 | 0.15, 0.55 | 412 | 0.55 | 0.28, 0.82 | 351 | −0.04 | −0.35, 0.27 | |
| Model 2 | 677 | 0.26 | 0.04, 0.48 | <0.01 | 381 | 0.50 | 0.22, 0.79 | 296 | −0.24 | −0.59, 0.11 |
| Waist circumference (cm) | ||||||||||
| U-sugars (μmol·L−1)/(mOsm·kg−1) | ||||||||||
| Model 1 | 763 | −0.09 | −1.68, 1.50 | 412 | 2.00 | −0.21, 4.21 | 351 | −2.94 | −5.18, −0.70 | |
| Model 2 | 677 | −0.20 | −1.84, 1.45 | <0.01 | 381 | 2.02 | −0.23, 4.28 | 296 | −3.79 | −6.19, −1.39 |
| Added sugar (E%) | ||||||||||
| Model 1 | 991 | 0.24 | 0.11, 0.37 | 533 | 0.34 | 0.14, 0.53 | 458 | 0.13 | −0.05, 0.30 | |
| Model 2 | 889 | 0.15 | 0.01, 0.29 | 0.05 | 493 | 0.25 | 0.03, 0.46 | 396 | 0.05 | −0.14, 0.24 |
| Composite measure | ||||||||||
| Model 1 | 763 | 1.00 | 0.49, 1.51 | 412 | 1.34 | 0.68, 2.00 | 351 | 0.23 | −0.60, 1.06 | |
| Model 2 | 677 | 0.76 | 0.22, 1.30 | <0.01 | 381 | 1.19 | 0.51, 1.88 | 296 | 0.19 | −1.09, 0.70 |
| Total cholesterol (mmol/L) | ||||||||||
| U-sugars (μmol·L−1)/(mOsm·kg−1) | ||||||||||
| Model 1 | 763 | −0.08 | −0.22, 0.05 | 412 | −0.06 | −0.23, 0.11 | 351 | −0.11 | −0.33, 0.11 | |
| Model 2 | 677 | −0.14 | −0.28, 0.01 | 0.91 | 381 | −0.12 | −0.30, 0.06 | 296 | −0.15 | −0.40, 0.10 |
| Added sugar (E%) | ||||||||||
| Model 1 | 990 | −0.006 | −0.02, 0.01 | 532 | −0.009 | −0.02, 0.01 | 458 | −0.002 | −0.02, 0.02 | |
| Model 2 | 888 | −0.009 | −0.02, 0.004 | 0.41 | 492 | −0.02 | −0.03, 0.0003 | 396 | −0.001 | −0.02, 0.02 |
| Composite measure | ||||||||||
| Model 1 | 763 | −0.02 | −0.06, 0.03 | 412 | −0.02 | −0.07, 0.04 | 351 | −0.01 | −0.09, 0.07 | |
| Model 2 | 677 | −0.03 | −0.07, 0.02 | 0.69 | 381 | −0.03 | −0.08, 0.03 | 296 | −0.02 | −0.11, 0.08 |
| Triglycerides (mmol/L) | ||||||||||
| U-sugars (μmol·L−1)/(mOsm·kg−1) | ||||||||||
| Model 1 | 757 | 0.04 | −0.05, 0.13 | 409 | 0.02 | −0.07, 0.11 | 348 | 0.06 | −0.11, 0.23 | |
| Model 2 | 671 | 0.02 | −0.08, 0.11 | 0.96 | 378 | 0.007 | −0.09, 0.11 | 293 | −0.01 | −0.20, 0.18 |
| Added sugar (E%) | ||||||||||
| Model 1 | 980 | 0.007 | −0.001, 0.01 | 527 | −0.00001 | −0.01, 0.01 | 453 | 0.01 | −0.001, 0.02 | |
| Model 2 | 878 | 0.003 | −0.01, 0.01 | 0.49 | 487 | −0.004 | −0.01, 0.01 | 391 | 0.006 | −0.01, 0.02 |
| Composite measure | ||||||||||
| Model 1 | 757 | 0.03 | −0.00001, 0.06 | 409 | 0.01 | −0.02, 0.04 | 348 | 0.06 | −0.01, 0.12 | |
| Model 2 | 671 | 0.02 | −0.01, 0.05 | 0.49 | 378 | 0.003 | −0.03, 0.03 | 293 | 0.03 | −0.03, 0.10 |
| HDL cholesterol (mmol/L) | ||||||||||
| U-sugars (μmol·L−1)/(mOsm·kg−1) | ||||||||||
| Model 1 | 763 | −0.06 | −0.13, −0.003 | 412 | −0.10 | −0.19, −0.01 | 351 | −0.02 | −0.10, 0.06 | |
| Model 2 | 677 | −0.04 | −0.11, 0.02 | 0.16 | 381 | −0.07 | −0.17, 0.02 | 296 | 0.01 | −0.07, 0.09 |
| Added sugar (E%) | ||||||||||
| Model 1 | 990 | −0.02 | −0.02, −0.01 | 532 | −0.02 | −0.03, −0.01 | 458 | −0.01 | −0.02, −0.005 | |
| Model 2 | 888 | −0.01 | −0.02, −0.01 | 0.04 | 492 | −0.02 | −0.02, −0.01 | 396 | −0.009 | −0.02, −0.002 |
| Composite measure | ||||||||||
| Model 1 | 763 | −0.04 | −0.06, −0.02 | 412 | −0.05 | −0.08, −0.02 | 351 | −0.03 | −0.06, −0.01 | |
| Model 2 | 677 | −0.03 | −0.05, −0.01 | 0.32 | 381 | −0.03 | −0.06, −0.001 | 296 | −0.03 | −0.06, 0.002 |
| LDL cholesterol (mmol/L) | ||||||||||
| U-sugars (μmol·L−1)/(mOsm·kg−1) | ||||||||||
| Model 1 | 763 | −0.06 | −0.18, 0.06 | 412 | −0.02 | −0.17, 0.13 | 351 | −0.11 | −0.31, 0.09 | |
| Model 2 | 677 | −0.13 | −0.26, 0.01 | 0.66 | 381 | −0.09 | −0.26, 0.07 | 296 | −0.16 | −0.39, 0.07 |
| Added sugar (E%) | ||||||||||
| Model 1 | 989 | 0.006 | −0.004, 0.02 | 531 | 0.006 | −0.01, 0.02 | 458 | 0.007 | −0.01, 0.02 | |
| Model 2 | 887 | 0.002 | −0.01, 0.01 | 0.68 | 491 | −0.003 | −0.02, 0.01 | 396 | 0.008 | −0.01, 0.03 |
| Composite measure | ||||||||||
| Model 1 | 763 | 0.01 | −0.03, 0.05 | 412 | 0.02 | −0.03, 0.06 | 351 | 0.006 | −0.07, 0.08 | |
| Model 2 | 677 | −0.006 | −0.05, 0.04 | 0.90 | 381 | −0.006 | −0.06, 0.04 | 296 | 0.008 | −0.07, 0.09 |
| Systolic BP (mmHg) | ||||||||||
| U-sugars (μmol·L−1)/(mOsm·kg−1) | ||||||||||
| Model 1 | 761 | 2.92 | 1.13, −4.70 | 410 | 4.22 | 1.74, 6.71 | 351 | 1.54 | −0.98, 4.05 | |
| Model 2 | 675 | 2.95 | 0.99, 4.92 | 0.22 | 379 | 4.63 | 1.96, 7.30 | 296 | 1.30 | −1.55, 4.16 |
| Added sugar (E%) | ||||||||||
| Model 1 | 988 | −0.09 | −0.24, 0.05 | 530 | −0.02 | −0.23, 0.20 | 458 | −0.12 | −0.31, 0.07 | |
| Model 2 | 886 | −0.09 | −0.26, 0.08 | 0.87 | 490 | −0.02 | −0.27, 0.22 | 396 | −0.09 | −0.31, 0.13 |
| Composite measure | ||||||||||
| Model 1 | 761 | 0.48 | −0.11, 1.06 | 410 | 0.89 | 0.13, 1.66 | 351 | 0.13 | −0.79, 1.06 | |
| Model 2 | 675 | 0.46 | −0.19, 1.12 | 0.55 | 379 | 1.01 | 0.17, 1.85 | 296 | −0.09 | −1.13, 0.96 |
| Diastolic BP (mmHg) | ||||||||||
| U-sugars (μmol·L−1)/(mOsm·kg−1) | ||||||||||
| Model 1 | 761 | 1.10 | −0.13, 2.33 | 410 | 1.80 | 0.16, 3.43 | 351 | 0.17 | −1.71, 2.04 | |
| Model 2 | 675 | 1.30 | −0.01, 2.62 | 0.43 | 379 | 1.81 | 0.07, 3.55 | 296 | 0.58 | −1.48, 2.64 |
| Added sugar (E%) | ||||||||||
| Model 1 | 988 | 0.03 | −0.07, 0.13 | 530 | 0.008 | −0.13, 0.15 | 458 | 0.05 | −0.09, 0.20 | |
| Model 2 | 886 | −0.01 | −0.12, 0.10 | 0.98 | 490 | −0.02 | −0.18, 0.14 | 396 | 0.003 | −0.15, 0.16 |
| Composite measure | ||||||||||
| Model 1 | 761 | 0.54 | 0.14, 0.94 | 410 | 0.49 | −0.01, 0.99 | 351 | 0.60 | −0.08, 1.28 | |
| Model 2 | 675 | 0.45 | 0.02, 0.88 | 0.86 | 379 | 0.48 | −0.06, 1.02 | 296 | 0.41 | −0.34, 1.16 |
| Fasting glucose (mmol/L) | ||||||||||
| U-sugars (μmol·L−1)/(mOsm·kg−1) | ||||||||||
| Model 1 | 762 | 0.09 | −0.003, 0.19 | 412 | 0.14 | 0.04, 0.25 | 350 | 0.01 | −0.15, 0.18 | |
| Model 2 | 677 | 0.10 | 0.0003, 0.20 | 0.22 | 381 | 0.16 | 0.05, 0.26 | 296 | 0.03 | −0.17, 0.22 |
| Added sugar (E%) | ||||||||||
| Model 1 | 990 | −0.007 | −0.01, 0.001 | 533 | −0.003 | −0.01, 0.01 | 457 | −0.01 | −0.02, −0.00001 | |
| Model 2 | 889 | −0.008 | −0.02, 0.001 | 0.04 | 493 | −0.002 | −0.01, 0.01 | 396 | −0.01 | −0.03, 0.001 |
| Composite measure | ||||||||||
| Model 1 | 762 | −0.0003 | −0.03, 0.03 | 412 | 0.009 | −0.02, 0.04 | 350 | −0.03 | −0.09, 0.03 | |
| Model 2 | 677 | −0.0004 | −0.03, 0.03 | 0.11 | 381 | 0.01 | −0.02, 0.05 | 296 | −0.03 | −0.10, 0.04 |
Total cholesterol, triglycerides, HDL, and LDL cholesterol and fasting glucose are measured in plasma. U-sugars are log10-transformed. The composite measure is the first PC of the two variables U-sugars and added sugars.
Model 1 is adjusted for age and sex (and energy intake for added sugar and the composite measure).
Model 2 is additionally adjusted for educational level, LTPA, smoking status, alcohol habits, and fiber density. Regressions with total cholesterol, triglycerides, HDL, and LDL cholesterol are additionally adjusted for usage of lipid lowering drugs and regressions with systolic and diastolic BP are additionally adjusted for usage of antihypertensive drugs.
U-sugars, sum of urinary sucrose and fructose; PC, principal component; BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; BP, blood pressure; LTPA, leisure-time physical activity.